Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Atomo Diagnostics Limited (AT1.AX)

0.0190
+0.0010
+(5.56%)
At close: May 2 at 4:10:09 PM GMT+10

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Mr. John Michael Kelly Founder, CEO, MD & Director 476.48k -- --
Ms. Chandra Sukumar Chief Operating Officer 298.43k -- --
Suzy Elhlou Finance Manager -- -- --
Mr. Mathew Watkins C.A. Company Secretary -- -- --

Atomo Diagnostics Limited

3-5 George Street
Level 1
Leichhardt, NSW 2040
Australia
61 2 9099 4750 https://atomodiagnostics.com
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Corporate Governance

Atomo Diagnostics Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 27, 2025 at 10:50 PM UTC

Atomo Diagnostics Limited Earnings Date

Recent Events

Related Tickers